UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 270

Sortiert nach

Pathological features and their prognostic impacts on oral cavity cancer patients among different subsites - A singe institute's experience in Taiwan

Scientific reports, 2017-08, Vol.7 (1), p.7451-9, Article 7451

2017

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the benefit and use of multidisciplinary teams in the treatment of head and neck cancer

Oral oncology, 2016-08, Vol.59, p.73-79

2016

Link zum Volltext

Verfügbarkeit prüfen

Maintenance metronomic chemotherapy for metastatic/recurrent nasopharyngeal carcinoma

Head & neck, 2022-06, Vol.44 (6), p.1453-1461

2022

Link zum Volltext

Verfügbarkeit prüfen

Low cardiac dose and neutrophil-to-lymphocyte ratio predict overall survival in inoperable esophageal squamous cell cancer patients after chemoradiotherapy

Scientific reports, 2021-03, Vol.11 (1), p.6644-6644, Article 6644

2021

Link zum Volltext

Verfügbarkeit prüfen

Effects of Epstein‐Barr virus viral load and different treatment modality for stage III nasopharyngeal carcinoma

Head & neck, 2020-08, Vol.42 (8), p.1765-1774

2020

Link zum Volltext

Verfügbarkeit prüfen

Lymph node ratio as a prognostic factor in head and neck cancer patients

Radiation oncology (London, England), 2015-08, Vol.10 (1), p.181-181, Article 181

2015

Link zum Volltext

Verfügbarkeit prüfen

Carotid blowout in patients with head and neck cancer: Associated factors and treatment outcomes

Head & neck, 2015-02, Vol.37 (2), p.265-272

2015

Link zum Volltext

Verfügbarkeit prüfen

Osteoradionecrosis of mandible bone in patients with oral cancer-associated factors and treatment outcomes

Head & neck, 2016-05, Vol.38 (5), p.762-768

2016

Link zum Volltext

Verfügbarkeit prüfen

Metronomic Adjuvant Chemotherapy Improves Treatment Outcome in Nasopharyngeal Carcinoma Patients With Postradiation Persistently Detectable Plasma Epstein-Barr Virus Deoxyribonucleic Acid

International journal of radiation oncology, biology, physics, 2014-05, Vol.89 (1), p.21-29

2014

Link zum Volltext

Verfügbarkeit prüfen

Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis

Oral oncology, 2021-08, Vol.119, p.105358, Article 105358

2021

Link zum Volltext

Verfügbarkeit prüfen

Cardiac Dose Predicts the Response to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma

Cancers, 2023-09, Vol.15 (18), p.4580

2023

Link zum Volltext

Verfügbarkeit prüfen

Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma

The New England journal of medicine, 2004-06, Vol.350 (24), p.2461-2470

2004

Link zum Volltext

Verfügbarkeit prüfen

Fibronectin promotes nasopharyngeal cancer cell motility and proliferation

Biomedicine & pharmacotherapy, 2019-01, Vol.109, p.1772-1784

2019

Link zum Volltext

Verfügbarkeit prüfen

Evidence Underlying Recommendations and Payments from Industry to Authors of the National Comprehensive Cancer Network Guidelines

The oncologist (Dayton, Ohio), 2019-04, Vol.24 (4), p.498-504

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of somatic mutations in the D-loop of mitochondrial DNA on the survival of oral squamous cell carcinoma patients

PloS one, 2015-04, Vol.10 (4), p.e0124322-e0124322

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparison the clinical outcomes with altered versus conventional fractionated radiotherapy plus concurrent chemotherapy for advanced nasopharyngeal carcinoma

Head & neck, 2018-06, Vol.40 (6), p.1156-1163

2018

Link zum Volltext

Verfügbarkeit prüfen

Which nasopharyngeal cancer patients need adaptive radiotherapy?

BMC cancer, 2018-12, Vol.18 (1), p.1234-1234, Article 1234

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free Survival

Journal of clinical oncology, 2003-02, Vol.21 (4), p.631-637

2003

Link zum Volltext

Verfügbarkeit prüfen

Transoral robotic surgery for early T classification hypopharyngeal cancer

Head & neck, 2016-06, Vol.38 (6), p.857-862

2016

Link zum Volltext

Verfügbarkeit prüfen

Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma

Clinical cancer research, 2010-02, Vol.16 (3), p.1016-1024

2010

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial Genome Instability and mtDNA Depletion in Human Cancers

Annals of the New York Academy of Sciences, 2005-05, Vol.1042 (1), p.109-122

2005

Link zum Volltext

Verfügbarkeit prüfen

Comparison Long-term Outcome of Definitive Radiotherapy plus Different Chemotherapy Schedules in Patients with Advanced Nasopharyngeal Carcinoma

Scientific reports, 2018-01, Vol.8 (1), p.470, Article 470

2018

Link zum Volltext

Verfügbarkeit prüfen

Patient and oncologist perceptions regarding symptoms and impact on quality-of-life of oral mucositis in cancer treatment: results from the Awareness Drives Oral Mucositis PercepTion (ADOPT) study

Supportive care in cancer, 2018-07, Vol.26 (7), p.2191-2200

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 270

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(255)
Mit Volltextzugriff
(256)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(195)
Life Sciences & Biomedicine
(170)
Humans
(151)
Female
(78)
Male
(78)
Middle Aged
(77)
Adult
(65)
Oncology
(65)
Aged
(61)
Biological And Medical Sciences
(37)
Nasopharyngeal Carcinoma
(36)
Medical Sciences
(34)
Retrospective Studies
(32)
Animals
(29)
Chemotherapy
(29)
Surgery
(29)
Tumors
(27)
Otorhinolaryngology
(26)
Prognosis
(26)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial

Pathological features and their prognostic impacts on oral cavity cancer patients among different subsites - A singe institute's experience in Taiwan

Evaluation of the benefit and use of multidisciplinary teams in the treatment of head and neck cancer

Maintenance metronomic chemotherapy for metastatic/recurrent nasopharyngeal carcinoma

Low cardiac dose and neutrophil-to-lymphocyte ratio predict overall survival in inoperable esophageal squamous cell cancer patients after chemoradiotherapy

Effects of Epstein‐Barr virus viral load and different treatment modality for stage III nasopharyngeal carcinoma

Lymph node ratio as a prognostic factor in head and neck cancer patients

Carotid blowout in patients with head and neck cancer: Associated factors and treatment outcomes

Osteoradionecrosis of mandible bone in patients with oral cancer-associated factors and treatment outcomes

Metronomic Adjuvant Chemotherapy Improves Treatment Outcome in Nasopharyngeal Carcinoma Patients With Postradiation Persistently Detectable Plasma Epstein-Barr Virus Deoxyribonucleic Acid

Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis

Cardiac Dose Predicts the Response to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma

Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma

Fibronectin promotes nasopharyngeal cancer cell motility and proliferation

Evidence Underlying Recommendations and Payments from Industry to Authors of the National Comprehensive Cancer Network Guidelines

Impact of somatic mutations in the D-loop of mitochondrial DNA on the survival of oral squamous cell carcinoma patients

Comparison the clinical outcomes with altered versus conventional fractionated radiotherapy plus concurrent chemotherapy for advanced nasopharyngeal carcinoma

Which nasopharyngeal cancer patients need adaptive radiotherapy?

Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free Survival

Transoral robotic surgery for early T classification hypopharyngeal cancer

Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma

Mitochondrial Genome Instability and mtDNA Depletion in Human Cancers

Comparison Long-term Outcome of Definitive Radiotherapy plus Different Chemotherapy Schedules in Patients with Advanced Nasopharyngeal Carcinoma

Patient and oncologist perceptions regarding symptoms and impact on quality-of-life of oral mucositis in cancer treatment: results from the Awareness Drives Oral Mucositis PercepTion (ADOPT) study

Suchergebnisse filtern